CervoMed receives U.S. patent for neflamapimod in pure DLB to 2042

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to CervoMed receives U.S. patent for neflamapimod in pure DLB to 2042
(NASDAQ: CRVO) Delayed: 2.42 -0.01 (0.41%)
Previous Close $2.43    52 Week High $ 
Open $2.47    52 Week Low $ 
Day High $2.49    P/E N/A 
Day Low $2.42    EPS $ 
Volume 77,632